India Business News: Sentynl, under Zydus Lifesciences, acquired global rights for Zokinvy, the first FDA-approved Progeria treatment. An acquisition milestone in expandin
First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvyâ„¢ (lonafarnib) by the Japanese Ministry of.
First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.